CVS Caremark Corporation- Strategy and SWOT Report - Strategy and SWOT Report

Description

Company Overiew: CVS Caremark Corporation (CVS Caremark) is a provider of prescriptions and related health care services in the US. The company is headquartered in Woonsocket, Rhode Island and employed about 201,000 people as of December 31, 2010. The company recorded revenues of $96,413 million during the financial year ended December 2010 (FY2010), a decrease of 2.3% compared with FY2009. The operating profit of the company was $6,165 million during FY2010, a decrease of 4.2% compared with FY2009. The net profit was $3,427 million in FY2010, a decrease of 7.3% compared with FY2009.Report Description:CVS Caremark Corporation - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

- Detailed information on CVS Caremark Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting CVS Caremark Corporation in the form of a SWOT analysis
- An in-depth view of the business model of CVS Caremark Corporation including a breakdown and examination of key business segments
- Intelligence on CVS Caremark Corporation’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about CVS Caremark Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

CVS Caremark Corporation (CVS Caremark) is a provider of prescriptions and related health care services in the US. The company is headquartered in Woonsocket, Rhode Island and employed about 201,000 people as of December 31, 2010. The company recorded revenues of $96,413 million during the financial year ended December 2010 (FY2010), a decrease of 2.3% compared with FY2009. The operating profit of the company was $6,165 million during FY2010, a decrease of 4.2% compared with FY2009. The net profit was $3,427 million in FY2010, a decrease of 7.3% compared with FY2009.

Reasons to Purchase:

- Gain understanding of CVS Caremark Corporation and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess CVS Caremark Corporation as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on CVS Caremark Corporation’s business structure, strategy and prospects

Company Snapshot
CVS Caremark Corporation: Company Overview
CVS Caremark Corporation: Overview and Key Facts
CVS Caremark Corporation: Overview
CVS Caremark Corporation: Key Facts
CVS Caremark Corporation: Key Employees
CVS Caremark Corporation: Key Employee Biographies
CVS Caremark Corporation: Major Products and Services
CVS Caremark Corporation: Company History
CVS Caremark Corporation: Management Statement
CVS Caremark Corporation: Locations and Subsidiaries
CVS Caremark Corporation: Key Competitors
CVS Caremark Corporation: Company Analysis
CVS Caremark Corporation: Business Description
CVS Caremark Corporation: SWOT Analysis
CVS Caremark Corporation: SWOT Overview
CVS Caremark Corporation: Strengths
CVS Caremark Corporation: Weaknesses
CVS Caremark Corporation: Opportunities
CVS Caremark Corporation: Threats
CVS Caremark Corporation: Corporate Financial Deals Activity
CVS Caremark Corporation: Financial Deals Overview
CVS Caremark Corporation: Targets and Partners
CVS Caremark Corporation: Top Deals 2007 -YTD*2011
CVS Caremark Corporation: Advisors
CVS Caremark Corporation: Top Legal Advisors
CVS Caremark Corporation: Top Financial Advisors
CVS Caremark Corporation: Mergers and Acquisitions
CVS Caremark Corporation: Corporate Venturing
CVS Caremark Corporation: Partnership
CVS Caremark Corporation: Divestments
CVS Caremark Corporation: Recent Developments
CVS Caremark Corporation: News and Events Summary
CVS Caremark Corporation: Business Expansion
CVS Caremark Corporation: Contracts
CVS Caremark Corporation: Corporate Governance
CVS Caremark Corporation: Financial Performance
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: CVS Caremark Corporation: Key Facts
Table 2: CVS Caremark Corporation: Key Employees
Table 4: CVS Caremark Corporation: Key Competitors
Table 5: CVS Caremark Corporation: Deal Activity by Deal Type - Volume (TTM)
Table 6: CVS Caremark Corporation: Deal Activity by Deal Type - Volume (2007 - YTD*2011)
Table 7: CVS Caremark Corporation: M&A Average Deal Size - Value (US$m)
Table 8: CVS Caremark Corporation: Targets and Partners
Table 9: CVS Caremark Corporation: Top Deals 2007 -YTD*2011
Table 10: CVS Caremark Corporation: Legal Advisor Ranking by Value (US$m)
Table 11: CVS Caremark Corporation: Financial Advisor Ranking by Value (US$m)
Table 12: CVS Caremark Corporation: M&A Volume and Value Trend (2007 - YTD*2011)
Table 13: CVS Caremark Corporation: M&A Activity by Geography (2007 - YTD*2011)
Table 14: CVS Caremark Corporation: Corporate Venturing Volume and Value Trend (2007 - YTD*2011)
Table 15: CVS Caremark Corporation: Corporate Venturing by Geography (2007 - YTD*2011)
Table 16: CVS Caremark Corporation: Partnership Volume and Value Trend (2007 - YTD*2011)
Table 17: CVS Caremark Corporation: Partnership Trend by Deal Type (2007 - YTD*2011)
Table 18: CVS Caremark Corporation: Divestments Volume and Value Trend (2007 - YTD*2011)
Table 19: CVS Caremark Corporation: Divestments by Geography (2007 - YTD*2011)
Table 20: CVS Caremark Corporation: News and Events Summary
Table 21: CVS Caremark Corporation: Business Expansion
Table 22: CVS Caremark Corporation: Contracts
Table 23: CVS Caremark Corporation: Corporate Governance
Table 24: CVS Caremark Corporation: Financial Performance

List of Figures

Figure 1: CVS Caremark Corporation: Deal Activity by Deal Type - Volume (TTM)
Figure 2: CVS Caremark Corporation: Deal Activity by Deal Type - Volume (2007 - YTD*2011)
Figure 3: CVS Caremark Corporation: M&A Average Deal Size - Value (US$m)
Figure 4: CVS Caremark Corporation: M&A Volume and Value Trend (2007 - YTD*2011)
Figure 5: CVS Caremark Corporation: M&A Activity by Geography (2007 - YTD*2011)
Figure 6: CVS Caremark Corporation: Corporate Venturing Volume and Value Trend (2007 - YTD*2011)
Figure 7: CVS Caremark Corporation: Corporate Venturing by Geography (2007 - YTD*2011)
Figure 8: CVS Caremark Corporation: Partnership Volume and Value Trend (2007 - YTD*2011)
Figure 9: CVS Caremark Corporation: Partnership Trend by Deal Type (2007 - YTD*2011)
Figure 10: CVS Caremark Corporation: Divestments Volume and Value Trend (2007 - YTD*2011)
Figure 11: CVS Caremark Corporation: Divestments by Geography (2007 - YTD*2011)

Details

Publisher: MarketLine

Format: Unknown

Pages: 52

Publisher Reference: A12FEC31-0D18-4B30-82D2-DEE3DD74D9DE

Date Published: 2011-11-24

Date Added: 2012-02-24 09:33:04

Title
United States Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others 2013-01-30	Info
Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections 2011-05-18	Info
Drug Delivery Devices Market Outlook in the United States to 2016 - Inhalation Systems, Infusion Systems and Others 2010-08-24	Info
North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others 2013-01-30	Info
Europe Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others 2013-01-30	Info
Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others 2013-01-30	Info
Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others 2013-01-30	Info
South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others 2013-01-30	Info
Mexico Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others 2013-01-30	Info
South Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others 2013-01-30	Info

Associated Tags :: CVS Caremark Corporation, United States, Drug Delivery

Ordering

Purchasing
Select the report required - click the green button and follow the online instructions

Payment
BioPortfolio operates a secure e-commerce facility in partnership with Worldpay. Alternatively, pro-forma payment can be made by bank transfer.

Delivery Details
BioPortfolio manages the dispatch of report orders following payment - we use our best endeavors to get PDF files to our customers within the hour but in some circumstances delivery may take up to 12 hours.

User License
Reports are sold under license:

Single User - The report can only be used by the purchaser.
Site - The report can be shared between users at a single site/location.
Global/Enterprise - The user is free to distribute the report across their entire organization.

Publisher Info

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies.

MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to us as their first-stop resource for instantly accessible, reliable business information.

Topic Context

CVS Caremark Corporation

CVS Caremark Corporation (NYSE: CVS) is an integrated pharmacy services provider, combining a United States pharmaceutical services company with a U.S. pharmacy chain. CVS Caremark provides pharmacy services through its over 7,000 CVS/pharmacy and Longs ... [more]

Source: CVS Caremark Corporation on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL

Drug Delivery

Technical and commercial reports on the development of novel drug delivery products. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery technologies modify... [more]

Source: Drug Delivery on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL